利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

24 条记录 (耗时 0.022 秒)

    Connection management for an application in a computing platform
    2.
    发明授权
    Connection management for an application in a computing platform 有权
    计算平台中应用程序的连接管理

    公开(公告)号：US09262238B2

    公开(公告)日：2016-02-16

    申请号：US13363150

    申请日：2012-01-31

    申请人： Tobias Kunze ,  Ram Ranganathan ,  Krishna Raman ,  Rajat Chopra

    发明人： Tobias Kunze ,  Ram Ranganathan ,  Krishna Raman ,  Rajat Chopra

    IPC分类号： G06F9/46 ,  G06F9/54 ,  G06F9/445

    CPC分类号： G06F9/542 ,  G06F8/60

    摘要： A computing device detects an event generated by a first component that publishes a connection endpoint, the event indicating that the connection endpoint of the first component has been modified. The computing device determines a second component that subscribes to the connection endpoint. The computing device updates a location of the connection endpoint in a data structure associated with the second component to maintain a connection between the first component and the second component.

    摘要翻译： 计算设备检测由发布连接端点的第一组件生成的事件，该事件指示第一组件的连接端点已被修改。 计算设备确定预订连接端点的第二组件。 计算设备更新与第二组件相关联的数据结构中的连接端点的位置，以维持第一组件和第二组件之间的连接。

    MICROBIAL OILS ENRICHED IN POLYUNSATURATED FATTY ACIDS
    6.
    发明申请
    MICROBIAL OILS ENRICHED IN POLYUNSATURATED FATTY ACIDS 审中-公开
    微生物油在多糖脂肪酸中增加

    公开(公告)号：US20140323569A1

    公开(公告)日：2014-10-30

    申请号：US14234104

    申请日：2012-07-20

    申请人： Krishna Raman

    发明人： Krishna Raman

    IPC分类号： A61K31/232 ,  A61K31/202

    CPC分类号： A61K31/232 ,  A21D2/165 ,  A23D9/00 ,  A23K20/158 ,  A23L5/00 ,  A23L7/104 ,  A23L9/00 ,  A23L31/00 ,  A23L33/115 ,  A23V2002/00 ,  A61K31/202 ,  C11B1/00 ,  C11B1/10 ,  C11B3/04 ,  C11B3/06 ,  C11C3/003 ,  C11C3/10 ,  C12P7/6472 ,  C12R1/89 ,  A23V2200/326 ,  A23V2250/187 ,  A23V2250/1882

    摘要： The present invention is directed to microbial oils that are enriched in their content of polyunsaturated fatty acids, their esters, their acid salts, alcohols formed therefrom, and/or aldehydes formed therefrom. The present invention is further directed to compositions containing the enriched microbial oils and methods of making and using the enriched microbial oils. The present invention is also directed to isolated microorganisms as well as strains and mutants thereof, biomasses, microbial oils, compositions, and cultures; methods of producing the microbial oils, biomasses, and mutants; and methods of using the isolated microorganisms, biomasses, and microbial oils.

    摘要翻译： 本发明涉及富含多不饱和脂肪酸含量的微生物油，它们的酯，它们的酸盐，由其形成的醇和/或由其形成的醛。 本发明还涉及含有富集的微生物油的组合物和制备和使用富集的微生物油的方法。 本发明还涉及分离的微生物以及其菌株和突变体，生物质，微生物油，组合物和培养物; 生产微生物油，生物质和突变体的方法; 以及使用分离的微生物，生物质和微生物油的方法。

    COMPOSITIONS AND METHODS FOR REDUCING TRIGLYCERIDE LEVELS
    7.
    发明申请
    COMPOSITIONS AND METHODS FOR REDUCING TRIGLYCERIDE LEVELS 审中-公开
    用于降低TRIGLYCERIDE水平的组合物和方法

    公开(公告)号：US20100130608A1

    公开(公告)日：2010-05-27

    申请号：US12572263

    申请日：2009-10-01

    申请人： Alan Stuart RYAN ,  Edward B. Nelson ,  Jung Lee ,  Krishna Raman

    发明人： Alan Stuart RYAN ,  Edward B. Nelson ,  Jung Lee ,  Krishna Raman

    IPC分类号： A61K31/22 ,  A61K31/202 ,  A61P3/00

    CPC分类号： A61K31/232 ,  A61K31/20 ,  A61K31/201 ,  A61K2300/00

    摘要： The present invention is directed to methods of reducing plasma triglyceride level in subjects by administering docosahexaenoic acid (DHA). The method can comprise administering daily to the subject a dosage form comprising docosahexaenoic acid ester substantially free of eicosapentaenoic acid (EPA), wherein the DHA is derived from an algal source. In some embodiments, the method comprises administering daily to the subject a dosage form comprising DHA ester substantially free of EPA, wherein the DHA ester is about 60% to about 99.5% (w/w) of the total fatty acid content of the dosage form. In some embodiments, the method comprises administering daily to the subject a dosage form comprising about 200 mg to about 4 g of DHA ester substantially free of EPA. In some embodiments, the foregoing methods also result in a lowering of the amount of total cholesterol in the subject.

    摘要翻译： 本发明涉及通过施用二十二碳六烯酸（DHA）来减少受试者血浆甘油三酯水平的方法。 该方法可以包括向受试者施用基本上不含二十碳五烯酸（EPA）的二十二碳六烯酸酯的剂型，其中DHA来源于藻源。 在一些实施方案中，该方法包括向受试者施用包含基本上不含EPA的DHA酯的剂型，其中DHA酯为剂型总脂肪酸含量的约60％至约99.5％（w / w） 。 在一些实施方案中，该方法包括向受试者施用包含约200mg至约4g基本上不含EPA的DHA酯的剂型。 在一些实施方案中，前述方法还导致受试者中总胆固醇的量的降低。